Issue
Alert me when new journal issues are available via or via
Waldenstrom's Macroglobulinemia
Defining Waldenstrom's macroglobulinemia Steven P. Treon, Meletios Dimopoulos, Robert A. Kyle pages 107-109 Full Text | Full-Text PDF (73 KB)
Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia Roger G. Owen, Steven P. Treon, Ayad Al-Katib, Rafael Fonseca, Philip R. Greipp, Mary L. McMaster, Enrica Morra, Gerassimos A. Pangalis, Jesus F. San Miguel, Andrew R. Branagan, Meletios A. Dimopoulos pages 110-115 Abstract | Full Text | Full-Text PDF (74 KB)
Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia Robert A. Kyle, Steven P. Treon, Raymond Alexanian, Bart Barlogie, Magnus Björkholm, Madhav Dhodapkar, T.Andrew Lister, Giampaolo Merlini, Pierre Morel, Marvin Stone, Andrew R. Branagan, Véronique Leblond pages 116-120 Abstract | Full Text | Full-Text PDF (70 KB)
Treatment recommendations in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia Morie A. Gertz, Athanasios Anagnostopoulos, Kenneth Anderson, Andrew R. Branagan, Morton Coleman, Stanley R. Frankel, Sergio Giralt, Todd Levine, Nikhil Munshi, Alan Pestronk, Vincent Rajkumar, Steven P. Treon pages 121-126 Abstract | Full Text | Full-Text PDF (68 KB)
Uniform response criteria in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia Donna Weber, Steven P. Treon, Christos Emmanouilides, Andrew R. Branagan, John C. Byrd, Joan Bladé, Eva Kimby pages 127-131 Abstract | Full Text | Full-Text PDF (66 KB)
The malignant clone in Waldenstrom's macroglobulinemia Jitra Kriangkum, Brian J. Taylor, Michael J. Mant, Steven P. Treon, Andrew R. Belch, Linda M. Pilarski pages 132-135 Abstract | Full Text | Full-Text PDF (126 KB)
Origins of the malignant clone in typical Waldenstrom's macroglobulinemia Surinder S. Sahota, Francesco Forconi, Christian H. Ottensmeier, Freda K. Stevenson pages 136-141 Abstract | Full Text | Full-Text PDF (151 KB)
Genetics and cytogenetics of Waldenstrom's macroglobulinemia Roelandt F.J. Schop, Rafael Fonseca pages 142-145 Abstract | Full Text | Full-Text PDF (61 KB)
Familial Waldenstrom's macroglobulinemia Mary L. McMaster pages 146-152 Abstract | Full Text | Full-Text PDF (72 KB)
14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia Hervé Avet-Loiseau, Richard Garand, Laurence Lodé, Nelly Robillard, Régis Bataille pages 153-155 Abstract | Full Text | Full-Text PDF (54 KB)
Proteomic analyses in Waldenstrom's macroglobulinemia and other plasma cell dyscrasias Constantine S. Mitsiades, Nicholas Mitsiades, Steven P. Treon, Kenneth C. Anderson pages 156-160 Abstract | Full Text | Full-Text PDF (182 KB)
Dysregulation of apoptosis in Waldenstrom's macroglobulinemia does not involve nuclear factor kappa B activation Derek Leitch, Sharon L. Barrans, Andrew S. Jack, Roger G. Owen pages 161-164 Abstract | Full Text | Full-Text PDF (230 KB)
Abnormal expression of hyaluronan synthases in patients with Waldenstrom's macroglobulimenia Sophia Adamia, Mary Crainie, Jitra Kriangkum, Michael J. Mant, Andrew R. Belch, Linda M. Pilarski pages 165-168 Abstract | Full Text | Full-Text PDF (94 KB)
Long-term follow-up of IgM monoclonal gammopathy of undetermined significance R.A. Kyle, T.M. Therneau, S.V. Rajkumar, J.R. Offord, D.R Larson, M.F. Plevak, L.J. Melton pages 169-171 Abstract | Full Text | Full-Text PDF (54 KB)
Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy Enrica Morra, Clara Cesana, Catherine Klersy, Marzia Varettoni, Luigi Cavanna, Bianca Canesi, Elisabetta Tresoldi, Luciana Barbarano, Mario Lazzarino pages 172-177 Abstract | Full Text | Full-Text PDF (77 KB)
Malignant transformation in IgM monoclonal gammopathy of undetermined significance S. Montoto, M. Rozman, L. Rosiñol, E. Nadal, E. Giné, M. Aymerich, A. Ferrer, J. Esteve, F. Bosch, A. López-Guillermo, J. Bladé, E. Montserrat pages 178-181 Abstract | Full Text | Full-Text PDF (70 KB)
Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells Ellen D. Remstein, Curtis A. Hanson, Robert A. Kyle, Janice M. Hodnefield, Paul J. Kurtin pages 182-186 Abstract | Full Text | Full-Text PDF (228 KB)
Immunophenotypic analysis of Waldenstrom's macroglobulinemia J.F. San Miguel, M.B. Vidriales, E. Ocio, G. Mateo, F. Sánchez-Guijo, M.L. Sánchez, L. Escribano, A. Bárez, M.J. Moro, J. Hernández, C. Aguilera, R. Cuello, J. García-Frade, R. López, J. Portero, A. Orfao pages 187-195 Abstract | Full Text | Full-Text PDF (96 KB)
Developing diagnostic criteria in Waldenstrom's macroglobulinemia Roger G. Owen pages 196-200 Abstract | Full Text | Full-Text PDF (88 KB)
Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders Gerassimos A. Pangalis, Marie-Christine Kyrtsonis, Flora N. Kontopidou, Theodoros P. Vassilakopoulos, Marina P. Siakantaris, Maria N. Dimopoulou, Christos Kittas, Maria K. Angelopoulou pages 201-205 Abstract | Full Text | Full-Text PDF (65 KB)
Asymptomatic Waldenstrom's macroglobulinemia R. Alexanian, D. Weber, K. Delasalle, F. Cabanillas, M. Dimopoulos pages 206-210 Abstract | Full Text | Full-Text PDF (81 KB)
Prognostic factors in symptomatic Waldenstrom's macroglobulinemia Giampaolo Merlini, Luca Baldini, Chiara Broglia, Mario Comelli, Maria Goldaniga, Giovanni Palladini, Giorgio Lambertenghi Deliliers, Paolo G. Gobbi pages 211-215 Abstract | Full Text | Full-Text PDF (78 KB)
Prognostic factors in Waldenstrom's macroglobulinemia: Description of the complications during the evolution—preliminary results on 101 patients Laure Stalnikiewicz, Isabelle Carrotte-Lefebvre, Laurence Detourmignies, Christian Rose, Bruno Cazin, Véronique Leblond, Pierre Morel pages 216-219 Abstract | Full Text | Full-Text PDF (65 KB)
Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: An update of a US intergroup trial (SW0G S9003) Madhav V. Dhodapkar, Joth L. Jacobson, Morie A. Gertz, John J. Crowley, Bart Barlogie pages 220-225 Abstract | Full Text | Full-Text PDF (91 KB)
Patterns of clinical presentation, treatment, and outcome in patients with Waldenstrom's macroglobulinemia: A two-institution study M. Björkholm, E. Johansson, D. Papamichael, F. Celsing, J. Matthews, T.A. Lister, A.Z.S. Rohatiner pages 226-230 Abstract | Full Text | Full-Text PDF (76 KB)
Smouldering Waldenstrom's macroglobulinemia: Factors predicting evolution to symptomatic disease Clara Cesana, Sara Miqueleiz, Patrizia Bernuzzi, Elisabetta Tresoldi, Valentina Rossi, Giovanna D'Avanzo, Davide Filippini, Enrica Morra pages 231-235 Abstract | Full Text | Full-Text PDF (68 KB)
Waldenstrom's macroglobulinemia: A retrospective analysis of 40 patients from 1972 to 2001 S. Ngan, A.Z.S. Rohatiner, J. Matthews, A. Williams, J.A.L.A. Amess, A. Norton, T.A. Lister pages 236-238 Abstract | Full Text | Full-Text PDF (64 KB)
Fludarabine in Waldenstrom's macroglobulinemia Véronique Leblond, Sylvain Choquet pages 239-242 Abstract | Full Text | Full-Text PDF (56 KB)
2-chlorodeoxyadenosine alone and in combination for previously untreated Waldenstrom's macroglobulinemia Donna M. Weber, Meletios A. Dimopoulos, Kay Delasalle, Kim Rankin, Maria Gavino, Raymond Alexanian pages 243-247 Abstract | Full Text | Full-Text PDF (71 KB)
Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: Therapeutic applications and considerations Steven P. Treon, Abigail Kelliher, Beverly Keele, Stanley Frankel, Christos Emmanouilides, Eva Kimby, Robert Schlossman, Nicholas Mitsiades, Constantine Mitsiades, Frederic Preffer, Kenneth C. Anderson pages 248-252 Abstract | Full Text | Full-Text PDF (82 KB)
CD22 as a target of passive immunotherapy Alessandra Cesano, Urte Gayko pages 253-257 Abstract | Full Text | Full-Text PDF (74 KB)
Radioimmunotherapy for Waldenstrom's macroglobulinemia Christos Emmanouilides pages 258-261 Abstract | Full Text | Full-Text PDF (59 KB)
Angiogenesis in Waldenstrom's macroglobulinemia S.Vincent Rajkumar, Suzanne Hayman, Philip R. Greipp pages 262-264 Abstract | Full Text | Full-Text PDF (164 KB)
Treatment of Waldenstrom's macroglobulinemia with single-agent thalidomide or with the combination of clarithromycin, thalidomide and dexamethasone M.A. Dimopoulos, C. Tsatalas, A. Zomas, G. Hamilos, P. Panayiotidis, D. Margaritis, C. Matsouka, T. Economopoulos, N. Anagnostopoulos pages 265-269 Abstract | Full Text | Full-Text PDF (62 KB)
Treatment of Waldenstrom's macroglobulinemia with clarithromycin, low-dose thalidomide, and dexamethasone Morton Coleman, John Leonard, Larry Lyons, Hubert Szelenyi, Ruben Niesvizky pages 270-274 Abstract | Full Text | Full-Text PDF (66 KB)
Potential new therapeutics for Waldenstrom's macroglobulinemia Jerome B. Zeldis, Peter H. Schafer, Brydon L. Bennett, Frank Mercurio, David I. Stirling pages 275-281 Abstract | Full Text | Full-Text PDF (189 KB)
Role for high-dose therapy with autologous hematopoietic stem cell support in Waldenstrom's macroglobulinemia N.C. Munshi, B. Barlogie pages 282-285 Abstract | Full Text | Full-Text PDF (59 KB)
Autologous and allogeneic stem cell transplantation in Waldenstrom's macroglobulinemia: Review of the literature and future directions Athanasios Anagnostopoulos, Ana Aleman, Sergio Giralt pages 286-290 Abstract | Full Text | Full-Text PDF (64 KB)
Transplantation in Waldenstrom's macroglobulinemia—the French experience O. Tournilhac, V. Leblond, R. Tabrizi, R. Gressin, D. Senecal, N. Milpied, B. Cazin, M. Divine, B. Dreyfus, J.Y. Cahn, B. Pignon, B. Desablens, J.F. Perrier, J.O. Bay, P. Travade pages 291-296 Abstract | Full Text | Full-Text PDF (70 KB)
Modulation of the activity of Bcl-2 in Waldenstrom's macroglobulinemia using antisense oligonucleotides Gwen L. Nichols, C.A. Stein pages 297-299 Abstract | Full Text | Full-Text PDF (79 KB)
Oblimersen sodium (G3139 Bcl-2 antisense oligonucleotide) therapy in Waldenstrom's macroglobulinemia: A targeted approach to enhance apoptosis Stanley R. Frankel pages 300-304 Abstract | Full Text | Full-Text PDF (84 KB)
Dendritic cell-mediated immunization in macroglobulinemia Madhav V. Dhodapkar pages 305-308 Abstract | Full Text | Full-Text PDF (58 KB)
Novel biologically based therapies for Waldenstrom's macroglobulinemia Constantine S. Mitsiades, Nicholas Mitsiades, Paul G. Richardson, Steven P. Treon, Kenneth C. Anderson pages 309-312 Abstract | Full Text | Full-Text PDF (58 KB)
The Wayne State University Waldenstrom's Macroglobulinemia preclinical model for Waldenstrom's macroglobulinemia Ayad M. Al-Katib, Edith Mensah-Osman, Amro Aboukameel, Ramzi Mohammad pages 313-317 Abstract | Full Text | Full-Text PDF (173 KB)
Human monoclonal macroglobulins with antibody activity Marvin J. Stone, Yolonda G. McElroy, Alan Pestronk, Janet L. Reynolds, Joseph T. Newman, Alex W. Tong pages 318-324 Abstract | Full Text | Full-Text PDF (108 KB)
Amyloidosis with IgM monoclonal gammopathies Morie A. Gertz, Robert A. Kyle pages 325-328 Abstract | Full Text | Full-Text PDF (114 KB)
Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia? Joan Bladé, Silvia Montoto, Laura Rosiñol, Emili Montserrat pages 329-331 Abstract | Full Text | Full-Text PDF (57 KB)
Frontmatter
Editorial Board
page A1 Full Text | Full-Text PDF (30 KB)
Forthcoming issue page A1 Full Text | Full-Text PDF (25 KB)
Previous issues page A1 Full Text | Full-Text PDF (25 KB)
Future issues page A1 Full Text | Full-Text PDF (18 KB)
Copyright © 2010 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us | The content on this site is intended for health professionals.
